SBI Cards and Payment Services Limited

NSE: SBICARD · Financial Services · Lot size: 800

SBI Cards and Payment Services Limited Open Interest & PCR Analysis

590Updated 5 Jun 2026, 03:30 pm IST
PCR
0.57
Bearish signal
Max Pain
620
Spot below by ₹30
Total CE OI
10.65M
Call writers
Total PE OI
6.12M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-06-05

Frequently Asked Questions

What is SBI Cards and Payment Services Limited PCR (Put-Call Ratio) today?
SBI Cards and Payment Services Limited's current PCR is 0.57. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. SBI Cards and Payment Services Limited's PCR of 0.57 indicates bearish sentiment.
What is SBI Cards and Payment Services Limited OI buildup type today?
SBI Cards and Payment Services Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for SBI Cards and Payment Services Limited?
SBI Cards and Payment Services Limited has total CE (call) OI of 10652000 contracts and total PE (put) OI of 6116000 contracts for the nearest expiry. The PCR is 0.57.
How is open interest analysis useful for SBI Cards and Payment Services Limited trading?
OI analysis for SBI Cards and Payment Services Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for SBI Cards and Payment Services Limited?
SBI Cards and Payment Services Limited's max pain is ₹620 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.